Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Inhibrx Inc
INBXCurrent price
14.33 USD
-1.05 USD (-6.85%)
Last closed
15.45 USD
Company
inhibrx.com
ISIN
US45720L1070
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
234 654 320 USD
Yield for 12 month
-29.30 %
1Y
3Y
5Y
10Y
15Y
INBX
Inhibrx Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of biologic therapeutics for people with life-threatening conditions. Its therapeutic candidates includes INBRX-109, a tetravalent therapeutic candidate targeting death-receptor 5 that is in phase 2 clinical trial for the treatment of unresectable or metastatic conventional chondrosarcoma; and INBRX-106, a hexavalent sdAb-based therapeutic candidate targeting OX4 that is in phase 2 clinical trial for the treatment of metastatic solid tumor, non-small cell lung cancer, melanoma, head and neck cancer, gastric (GIST) and gastroesophageal adenocarcinoma (GEA) cancer, renal cell carcinoma, and urothelial (transitional) cell carcinoma. The company was incorporated in 2024 and is based in La Jolla, California. Address: 11025 North Torrey Pines Road, La Jolla, CA, United States, 92037
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
15 USDP/E ratio
0.1364Dividend Yield
–Current Year
+1 800 000 USD
Last Year
+2 178 000 USD
Current Quarter
+100 000 USD
Last Quarter
–
Current Year
+609 000 USD
Last Year
+2 178 000 USD
Current Quarter
-375 000 USD
Last Quarter
-360 000 USD
Key Figures INBX
1 year
3 years
5 years
10 years
EBITDA
-300 927 008 USD
Operating Margin TTM
PE Ratio
0.1364
Return On Assets TTM
-57.46 %
PEG Ratio
–
Return On Equity TTM
-2031.05 %
Wall Street Target Price
15 USD
Revenue TTM
1 687 000 USD
Book Value
15.15 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
233.3 %
Dividend Yield
–
Gross Profit TTM
-107 994 000 USD
Earnings per share
118.84 USD
Diluted Eps TTM
118.84 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
101974.22 %
Dividend Analytics INBX
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History INBX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation INBX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
0.1364
Forward PE
–
Enterprise Value Revenue
5.9072
Price Sales TTM
139.0956
Enterprise Value EBITDA
0.0058
Price Book MRQ
1.0697
Financials INBX
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators INBX
For 52 weeks
10.8 USD
39.79 USD
50 Day MA
15.78 USD
Shares Short Prior Month
742 518
200 Day MA
14.74 USD
Short Ratio
8.36
Shares Short
895 657
Short Percent
5.71 %
BeatStart